The NF-κB transcription factor RelA is required for the tolerogenic function of Foxp3+ regulatory T cells

Journal of Autoimmunity

Volumn 70, Issue , 2016, Pages 52-62

  Messina, Nicole ^a   Fulford, Thomas ^a   O'Reilly, Lorraine ^b,c   Loh, Wen Xian ^a   Motyer, Jessica M ^a   Ellis, Darcy ^a   McLean, Catriona ^d   Naeem, Haroon ^a   Lin, Ann ^b   Gugasyan, Raffi ^e   Slattery, Robyn M ^a   Grumont, Raelene J ^a   Gerondakis, Steve ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e BURNET INSTITUTE   (Australia)

Author keywords

Autoimmune disease; Conditional gene targeting; Nuclear factor of kappaB; Regulatory T cells; RelA

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HERMES ANTIGEN; L SELECTIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RELA; ANTIBODY; BIOLOGICAL MARKER; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FETUS; GENE; GENE EXPRESSION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RELA GENE; T LYMPHOCYTE ACTIVATION; ANIMAL; AUTOIMMUNITY; BLOOD; CLUSTER ANALYSIS; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOMARKERS; CLUSTER ANALYSIS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; IMMUNE TOLERANCE; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTOR RELA;

EID: 84962676799     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.03.017     Document Type: Article

References (61)

1. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
2. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
3. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
4. Schmidt A., Oberle N., Krammer P.H. Molecular mechanisms of treg-mediated T cell suppression. Front. Immunol. 2012, 3:51.
5. Sakaguchi S., Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T. Regulatory T cells: how do they suppress immune responses?. Int. Immunol. 2009, 21:1105-1111.
6. Cretney E., Kallies A., Nutt S.L. Differentiation and function of Foxp3(+) effector regulatory T cells. Trends Immunol. 2013, 34:74-80.
7. Liston A., Gray D.H. Homeostatic control of regulatory T cell diversity. Nat. Rev. Immunol. 2014, 14:154-165.
8. Feuerer M., Hill J.A., Kretschmer K., von Boehmer H., Mathis D., Benoist C. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5919-5924.
9. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
10. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
11. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
12. Hill J.A., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
13. Li X., Zheng Y. Regulatory T cell identity: formation and maintenance. Trends Immunol. 2015, 36:344-353.
14. Ohkura N., Hamaguchi M., Morikawa H., Sugimura K., Tanaka A., Ito Y., et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 2012, 37:785-799.
15. Samstein R.M., Arvey A., Josefowicz S.Z., Peng X., Reynolds A., Sandstrom R., et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 2012, 151:153-166.
16. Luo C.T., Li M.O. Transcriptional control of regulatory T cell development and function. Trends Immunol. 2013, 34:531-539.
17. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.
18. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 2009, 10:595-602.
19. Wohlfert E.A., Grainger J.R., Bouladoux N., Konkel J.E., Oldenhove G., Ribeiro C.H., et al. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J. Clin. Invest. 2011, 121:4503-4515.
20. Tartar D.M., VanMorlan A.M., Wan X., Guloglu F.B., Jain R., Haymaker C.L., et al. FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes. J. Immunol. 2010, 184:3377-3385.
21. Yu F., Sharma S., Edwards J., Feigenbaum L., Zhu J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat. Immunol. 2015, 16:197-206.
22. Chung Y., Tanaka S., Chu F., Nurieva R.I., Martinez G.J., Rawal S., et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 2011, 17:983-988.
23. Gerondakis S., Fulford T.S., Messina N.L., Grumont R.J. NF-kappaB control of T cell development. Nat. Immunol. 2014, 15:15-25.
24. Long M., Park S.G., Strickland I., Hayden M.S., Ghosh S. Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 2009, 31:921-931.
25. Guckel E., Frey S., Zaiss M.M., Schett G., Ghosh S., Voll R.E. Cell-intrinsic NF-kappaB activation is critical for the development of natural regulatory T cells in mice. PloS One 2011, 6:e20003.
26. Gerondakis S., Siebenlist U. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2010, 2:a000182.
27. Isomura I., Palmer S., Grumont R.J., Bunting K., Hoyne G., Wilkinson N., et al. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 2009, 206:3001-3014.
28. Chang J.H., Xiao Y., Hu H., Jin J., Yu J., Zhou X., et al. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat. Immunol. 2012, 13:481-490.
29. Chang J.H., Hu H., Sun S.C. Survival and maintenance of regulatory T cells require the kinase TAK1. Cell. Mol. Immunol. 2015, 12:572-579.
30. Muto G., Kotani H., Kondo T., Morita R., Tsuruta S., Kobayashi T., et al. TRAF6 is essential for maintenance of regulatory T cells that suppress Th2 type autoimmunity. PloS One 2013, 8:e74639.
31. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376:167-170.
32. Wan Y.Y., Flavell R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5126-5131.
33. Algul H., Treiber M., Lesina M., Nakhai H., Saur D., Geisler F., et al. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J. Clin. Invest. 2007, 117:1490-1501.
34. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28:546-558.
35. Grumont R.J., Gerondakis S. The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth & Differ. Mol. Biol. J. Am. Assoc. Cancer Res. 1994, 5:1321-1331.
36. Grumont R.J., Richardson I.B., Gaff C., Gerondakis S. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells. Cell Growth & Differ. Mol. Biol. J. Am. Assoc. Cancer Res. 1993, 4:731-743.
37. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
38. Ritchie M.E., Phipson B., Wu D., Hu Y., Law C.W., Shi W., et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015, 43:e47.
39. Mattioli I., Sebald A., Bucher C., Charles R.P., Nakano H., Doi T., et al. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J. Immunol. 2004, 172:6336-6344.
40. Lahl K., Loddenkemper C., Drouin C., Freyer J., Arnason J., Eberl G., et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007, 204:57-63.
41. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 2007, 8:277-284.
42. Gultner S., Kuhlmann T., Hesse A., Weber J.P., Riemer C., Baier M., et al. Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE. Eur. J. Immunol. 2010, 40:3403-3412.
43. Humrich J.Y., Morbach H., Undeutsch R., Enghard P., Rosenberger S., Weigert O., et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:204-209.
44. Komatsu N., Hori S. Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8959-8964.
45. Powrie F., Mason D. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med. 1990, 172:1701-1708.
46. Ruan Q., Kameswaran V., Tone Y., Li L., Liou H.C., Greene M.I., et al. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 2009, 31:932-940.
47. Beyersdorf N., Ding X., Tietze J.K., Hanke T. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1. Eur. J. Immunol. 2007, 37:3445-3454.
48. Levine A.G., Arvey A., Jin W., Rudensky A.Y. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 2014, 15:1070-1078.
49. Huehn J., Siegmund K., Lehmann J.C., Siewert C., Haubold U., Feuerer M., et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 2004, 199:303-313.
50. Cretney E., Xin A., Shi W., Minnich M., Masson F., Miasari M., et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 2011, 12:304-311.
51. Busse M., Krech M., Meyer-Bahlburg A., Hennig C., Hansen G. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance. J. Immunol. 2012, 189:1975-1982.
52. Grumont R.J., Gerondakis S. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J. Exp. Med. 2000, 191:1281-1292.
53. Zhu J., Shevach E.M. TCR signaling fuels T(reg) cell suppressor function. Nat. Immunol. 2014, 15:1002-1003.
54. Zhang R., Huynh A., Whitcher G., Chang J., Maltzman J.S., Turka L.A. An obligate cell-intrinsic function for CD28 in Tregs. J. Clin. Invest. 2013, 123:580-593.
55. Godfrey V.L., Wilkinson J.E., Russell L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 1991, 138:1379-1387.
56. Godfrey V.L., Wilkinson J.E., Rinchik E.M., Russell L.B. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:5528-5532.
57. Fairweather D., Frisancho-Kiss S., Rose N.R. Sex differences in autoimmune disease from a pathological perspective. Am. J. Pathol. 2008, 173:600-609.
58. Le Campion A., Pommier A., Delpoux A., Stouvenel L., Auffray C., Martin B., et al. IL-2 and IL-7 determine the homeostatic balance between the regulatory and conventional CD4+ T cell compartments during peripheral T cell reconstitution. J. Immunol. 2012, 189:3339-3346.
59. Pacholczyk R., Kern J. The T-cell receptor repertoire of regulatory T cells. Immunology 2008, 125:450-458.
60. Okada M., Hibino S., Someya K., Yoshmura A. Regulation of regulatory T cells: epigenetics and plasticity. Adv. Immunol. 2014, 124:249-273.
61. Sawant D.V., Vignali D.A. Once a Treg, always a Treg?. Immunol. Rev. 2014, 259:173-191.